GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hindustan Bio Sciences Ltd (BOM:532041) » Definitions » Shiller PE Ratio

Hindustan Bio Sciences (BOM:532041) Shiller PE Ratio : (As of Mar. 26, 2025)


View and export this data going back to 1996. Start your Free Trial

What is Hindustan Bio Sciences Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Hindustan Bio Sciences Shiller PE Ratio Historical Data

The historical data trend for Hindustan Bio Sciences's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hindustan Bio Sciences Shiller PE Ratio Chart

Hindustan Bio Sciences Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Hindustan Bio Sciences Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Hindustan Bio Sciences's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Hindustan Bio Sciences's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hindustan Bio Sciences's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hindustan Bio Sciences's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Hindustan Bio Sciences's Shiller PE Ratio falls into.



Hindustan Bio Sciences Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Hindustan Bio Sciences's E10 for the quarter that ended in Dec. 2024 is calculated as:

For example, Hindustan Bio Sciences's adjusted earnings per share data for the three months ended in Dec. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=-0.04/158.3229*158.3229
=-0.040

Current CPI (Dec. 2024) = 158.3229.

Hindustan Bio Sciences Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201503 -0.230 97.163 -0.375
201506 0.030 99.841 0.048
201509 0.030 101.753 0.047
201512 -0.150 102.901 -0.231
201603 -1.950 102.518 -3.011
201606 -0.130 105.961 -0.194
201609 -0.100 105.961 -0.149
201612 -0.100 105.196 -0.151
201703 -0.160 105.196 -0.241
201706 -0.110 107.109 -0.163
201709 -0.060 109.021 -0.087
201712 -0.010 109.404 -0.014
201803 -2.040 109.786 -2.942
201806 -0.002 111.317 -0.003
201809 0.020 115.142 0.028
201812 0.070 115.142 0.096
201903 0.020 118.202 0.027
201906 0.140 120.880 0.183
201909 -0.140 123.175 -0.180
201912 0.010 126.235 0.013
202003 0.070 124.705 0.089
202006 0.050 127.000 0.062
202009 0.030 130.118 0.037
202012 -0.110 130.889 -0.133
202103 -0.890 131.771 -1.069
202106 -0.070 134.084 -0.083
202109 -0.050 135.847 -0.058
202112 -0.002 138.161 -0.002
202203 -0.370 138.822 -0.422
202206 -0.020 142.347 -0.022
202209 -0.070 144.661 -0.077
202212 0.050 145.763 0.054
202303 0.010 146.865 0.011
202306 -0.120 150.280 -0.126
202309 0.060 151.492 0.063
202312 0.070 152.924 0.072
202403 0.043 153.035 0.044
202406 0.080 155.789 0.081
202409 -0.050 157.882 -0.050
202412 -0.040 158.323 -0.040

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Hindustan Bio Sciences  (BOM:532041) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Hindustan Bio Sciences Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Hindustan Bio Sciences's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Hindustan Bio Sciences Business Description

Traded in Other Exchanges
N/A
Address
Road No. 2, Banjara Hills, H.No. 8-2-269/S, Plot No. 31, Sagar Co-Operative Housing Society, Hyderabad, TG, IND, 500034
Hindustan Bio Sciences Ltd is an India-based company operating in the pharmaceutical and biotechnology sector. It is engaged in the trading of Drugs and Medicines. The company markets a nephrology product, Recombinant Human Erythropoietin, which is useful for the treatment of anemia associated with chronic renal failure. In addition, the firm also manufactures and markets pharmaceutical products in different forms such as tablets, capsules, drops, externals, and syrups. Its other formulations comprise Pantorest, Maxion, Edinil, Aromycin, Livohin, and others. Geographically, the group sells its products within India and also exports it to other countries.

Hindustan Bio Sciences Headlines

No Headlines